HTG Molecular Diagnostics Inc.
Save
5.54K
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Diagnostics & Research
Industry
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel.
Similar securities
Based on sector and market capitalization
Report issue